603367 辰欣藥業
按盤價 
14.400 +0.990 (+7.383%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.687 | 9.428 | 6.738 | 6.781 | 9.362 |
| 總資產報酬率 ROA (%) | 3.696 | 7.367 | 5.311 | 5.334 | 7.501 |
| 投入資產回報率 ROIC (%) | 4.446 | 8.878 | 6.399 | 6.331 | 8.786 | 邊際利潤分析 |
| 銷售毛利率 (%) | 57.747 | 58.788 | 55.995 | 55.463 | 57.245 |
| 營業利潤率 (%) | 14.012 | 13.280 | 8.966 | 8.841 | 13.191 |
| 息稅前利潤/營業總收入 (%) | 13.276 | 12.598 | 8.320 | 8.646 | 13.279 |
| 淨利潤/營業總收入 (%) | 13.220 | 11.775 | 8.664 | 8.827 | 11.904 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 92.449 | 99.968 | 95.161 | 73.120 | 78.290 |
| 價值變動淨收益/利潤總額(%) | 9.154 | 5.663 | 4.249 | 19.761 | 19.898 |
| 營業外收支淨額/利潤總額(%) | 0.665 | 0.550 | 0.439 | 0.509 | -0.032 | 償債能力分析 |
| 流動比率 (X) | 3.559 | 3.628 | 3.701 | 3.400 | 3.076 |
| 速動比率 (X) | 2.961 | 3.111 | 3.249 | 2.912 | 2.630 |
| 資產負債率 (%) | 19.891 | 21.415 | 21.412 | 20.556 | 22.119 |
| 帶息債務/全部投入資本 (%) | 2.973 | 4.567 | 4.527 | 2.434 | 7.628 |
| 股東權益/帶息債務 (%) | 3,212.105 | 2,063.545 | 2,078.695 | 3,938.352 | 1,191.259 |
| 股東權益/負債合計 (%) | 400.588 | 364.479 | 365.406 | 386.412 | 352.036 |
| 利息保障倍數 (X) | -15.996 | -16.697 | -12.136 | -36.002 | 144.962 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 65.965 | 58.758 | 54.201 | 47.925 | 54.075 |
| 存貨周轉天數 (天) | 154.472 | 126.130 | 118.211 | 124.666 | 134.409 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
